A detailed history of Washington Trust Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 8,653 shares of MRK stock, worth $859,848. This represents 0.09% of its overall portfolio holdings.

Number of Shares
8,653
Previous 8,977 3.61%
Holding current value
$859,848
Previous $1.11 Million 11.61%
% of portfolio
0.09%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$111.15 - $128.97 $36,012 - $41,786
-324 Reduced 3.61%
8,653 $982,000
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $24,883 - $26,724
-201 Reduced 2.19%
8,977 $1.11 Million
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $8,153 - $9,500
72 Added 0.79%
9,178 $1.21 Million
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $68,422 - $74,460
-683 Reduced 6.98%
9,106 $992,000
Q3 2023

Oct 18, 2023

BUY
$102.95 - $114.33 $1,544 - $1,714
15 Added 0.15%
9,789 $1.01 Million
Q2 2023

Jul 27, 2023

BUY
$108.61 - $118.38 $1,629 - $1,775
15 Added 0.15%
9,774 $1.13 Million
Q1 2023

May 04, 2023

BUY
$102.94 - $114.86 $1,441 - $1,608
14 Added 0.14%
9,759 $1.04 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $1,486 - $1,905
17 Added 0.17%
9,745 $1.08 Million
Q3 2022

Oct 14, 2022

SELL
$84.53 - $94.96 $5,325 - $5,982
-63 Reduced 0.64%
9,728 $838,000
Q2 2022

Jul 25, 2022

SELL
$83.49 - $94.64 $231,100 - $261,963
-2,768 Reduced 22.04%
9,791 $893,000
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $9,850 - $11,041
-134 Reduced 1.06%
12,559 $1.03 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $917,450 - $1.15 Million
12,693 New
12,693 $972,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.